Using next-generation sequencing to detect Omicron
Experts at Thermo Fisher Scientific and MAKO Medical explain how NGS offers new hope in combating COVID-19
Stay updated with breaking news from Genexus System. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Experts at Thermo Fisher Scientific and MAKO Medical explain how NGS offers new hope in combating COVID-19
Collaboration extends global reach for Thermo Fisher’s rapid next-generation sequencing technology
/PRNewswire/ -- USA News Group - Nearly 10% of the estimated ~1.9 million new cancer cases in the USA will be diagnosed as leukemia, lymphoma and myeloma....
FT. MYERS, FL / ACCESSWIRE / December 10, 2021 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services and global oncology contract research services, announced
Thermo Fisher's next-generation sequencing (NGS) technology offers researchers fast, real-time sequencing-data acquisition and easy data sharing across the global scientific community, as suggested by the US Food and Drug Administration (FDA) and European Centre for Disease Prevention and Control (ECDC)